Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Dongling Zhu"'
Autor:
Junyi Liu, Ming Tang, Dongling Zhu, Ge Ruan, Sijuan Zou, Zhaoting Cheng, Xiaohua Zhu, Yuankai Zhu
Publikováno v:
EJNMMI Research, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Background Owing to the advances in diagnosis and therapy, survival or remission rates for lymphoma have improved prominently. Apart from the lymphoma- and chemotherapy-related somatic symptom burden, increasing attention has been drawn to t
Externí odkaz:
https://doaj.org/article/eff40a7567014aabba63ed151458f4f5
Autor:
Dongling Zhu, Shuang Song, Dongdong Wang, Dong Kuang, Siyuan Cheng, Jianyuan Zhou, Sijuan Zou
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Perivascular epithelioid cell tumor (PEComa), an uncommon mesenchymal neoplasm, arises from specialized perivascular epithelioid cells exhibiting distinct features of smooth muscle and melanocytic differentiation with unpredictable behavior. PEComa t
Externí odkaz:
https://doaj.org/article/d5eb4b185f344b66baf1672ea778f749
Autor:
Ling Gao, Fan Qiu, Hao Cao, Hao Li, Gonghua Dai, Teng Ma, Yanshan Gong, Wei Luo, Dongling Zhu, Zhixuan Qiu, Ping Zhu, Shuguang Chu, Huangtian Yang, Zhongmin Liu
Publikováno v:
Theranostics. 13:685-703
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff663f34efebf8eec1d7ca4431556c0c
https://doi.org/10.7150/thno.73568
https://doi.org/10.7150/thno.73568
Autor:
Zhao Huang, Jingyuan Wen, Yufei Wang, Shenqi Han, Zhen Li, Xuemei Hu, Dongling Zhu, Zhenxiong Wang, Junnan Liang, Huifang Liang, Xiao-ping Chen, Bixiang Zhang
Publikováno v:
Frontiers of Medicine. 16:551-573
Patients with hepatocellular carcinoma (HCC) and bone metastasis (BM) suffer from greatly reduced life quality and a dismal prognosis. However, BM in HCC has long been overlooked possibly due to its relatively low prevalence in previous decades. To d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a62e9f6a21572a53d57f2fb39a6c1fb
https://doi.org/10.1007/s11684-022-0928-z
https://doi.org/10.1007/s11684-022-0928-z
Autor:
Teng Ma, Fan Qiu, Yanshan Gong, Hao Cao, Gonghua Dai, Daohan Sun, Dongling Zhu, Han Lei, Zhongmin Liu, Ling Gao
Publikováno v:
Theranostics; 2023, Vol. 13 Issue 11, p3826-3843, 18p
Autor:
Minglong Chen, Shi Gao, Hua Wu, Dongling Zhu, Xiaohua Zhu, Sijuan Zou, Lei Zhu, Yesen Li, Yushuang Qin, Siyuan Cheng
Publikováno v:
Biomaterials Science. 8:5656-5665
Glypican-3 (GPC3) is a diagnostic biomarker for hepatocellular carcinoma (HCC). Although numerous designs targeting GPC3 have been reported, the HCC diagnostic agents with specific tumor accumulation and low background, particularly in normal liver t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4f55c2addb3158a5b70974b8b2d7c02
https://doi.org/10.1039/d0bm00943a
https://doi.org/10.1039/d0bm00943a
Autor:
Yushuang, Qin, Siyuan, Cheng, Yesen, Li, Sijuan, Zou, Minglong, Chen, Dongling, Zhu, Shi, Gao, Hua, Wu, Lei, Zhu, Xiaohua, Zhu
Publikováno v:
Biomaterials science. 8(20)
Glypican-3 (GPC3) is a diagnostic biomarker for hepatocellular carcinoma (HCC). Although numerous designs targeting GPC3 have been reported, the HCC diagnostic agents with specific tumor accumulation and low background, particularly in normal liver t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a7e2ca0d96d1f7eff1c809ea54fda04c
https://pubmed.ncbi.nlm.nih.gov/32896851
https://pubmed.ncbi.nlm.nih.gov/32896851
Publikováno v:
Molecular Pharmaceutics. 15:1674-1681
Recently, various immuno-PET tracers based on monoclonal antibodies (mAbs), engineered scaffold proteins, and peptides were developed to target either programmed cell death protein 1 (PD-1) or prog...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::099d21771d343212f7a4421163f27808
https://doi.org/10.1021/acs.molpharmaceut.8b00062
https://doi.org/10.1021/acs.molpharmaceut.8b00062
Publikováno v:
Clinical nuclear medicine. 44(2)
Myopathy is an adverse effect of telbivudine. We describe a case of telbivudine-induced myopathy visualized on FDG PET/CT in a 75-year-old man with history of chronic HBV infection and hepatocellular carcinoma. FDG PET/CT images demonstrate no abnorm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c0c23bb1c62f84c09d7ee43d9738930
https://pubmed.ncbi.nlm.nih.gov/30608913
https://pubmed.ncbi.nlm.nih.gov/30608913
Publikováno v:
Molecular pharmaceutics. 15(4)
Recently, various immuno-PET tracers based on monoclonal antibodies (mAbs), engineered scaffold proteins, and peptides were developed to target either programmed cell death protein 1 (PD-1) or programmed cell death ligand 1 (PD-L1), showing promise i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e1950593d039d124b5059e843b3f7c9f
https://pubmed.ncbi.nlm.nih.gov/29502426
https://pubmed.ncbi.nlm.nih.gov/29502426